http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002512193-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10 |
| filingDate | 1999-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002512193-A |
| titleOfInvention | Use of carbohydrate corticosteroids for the manufacture of a medicament for treating mild / early forms of COPD (chronic obstructive pulmonary disease) |
| abstract | SUMMARY OF THE INVENTION The present invention is directed to treating chronic obstructive pulmonary disease (COPD) in patients having a FEV 1.0 value greater than 65% of the predicted value and a reversibility of less than 10% in a bronchodilation test. The use of carbohydrate corticosteroids for the manufacture of medicaments. The present invention further provides a method of treating COPD in a patient having an FEV 1.0 value greater than 65% of the predicted value and a reversibility of less than 10% in a bronchodilation test, wherein the patient in need of such treatment comprises: A method for administering a therapeutically effective amount of a carbohydrate corticosteroid. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007533706-A |
| priorityDate | 1998-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.